J&J, AstraZeneca resume trials of COVID-19 vaccines

J&J, AstraZeneca resume trials of COVID-19 vaccines

By Excelsio Media on October 24, 2020 Also in AstraZeneca, covid-19, Johnson & Johnson, vaccine

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.

Comments

Comentarios de Facebook

Subscribe to: Post Comments (Atom)